Last Updated: 05/14/18
Post-Treatment Surveillance Workshop
Powerpoint Slides from the Workshop
| Title | Presenter |
|---|---|
| Introduction and Meeting Objectives | Lalitha Shankar, MD, PhD |
| Plenary 1: Overview of current issues in post-treatment surveillance to set the stage for the purpose of the workshop. | |
| NCI Perspectives | Jeff Abrams, MD |
| Screening Breast Cancer Patients for Occult Recurrence: Current Guidelines and Efforts to Change the Dogma | Daniel Hayes, MD |
| Plenary 2: Current issues in IMAGING in post-treatment surveillance. | |
| Overview | Mitch Schnall, MD, Ph.D |
| Anatomic Imaging | Larry Schwartz, MD |
| Molecular Imaging | Annick Van den Abbeele, MD |
| Plenary 3: Current issues in LIQUID BIOPSY in post-treatment surveillance. | |
| The Opportunities and Challenges in using ctDNA in Post Treatment Surveillance | James Carl Barrett, Ph.D |
| Liquid Biopsies with Circulating Tumor Cells: Houston, we have a problem! | Howard Scher, MD |
| Title TBD | Siraj Ali, MD, Ph.D |
| Plenary 4: Current issues from the PATIENT PERSPECTIVE in post-treatment surveillance. | |
| Patient Perspectives on Post-Treatment Surveillance: Overview | Paul Jacobsen, Ph.D |
| Cancer Survivorship: Lost in Transition | Erin Price |
| What Matters Most: A Patient Perspective on Post-Treatment Surveillance. | Janet Freeman-Daily |